pirfenidone has been researched along with Libman-Sacks Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Deng, L; Hu, X; Zhang, Y; Zhou, J | 1 |
| D'Arcy, C; De la Harpe Golden, P; Kelly, AS; Lally, A | 1 |
| Man, XY; Yang, BB; Zheng, M | 1 |
3 other study(ies) available for pirfenidone and Libman-Sacks Disease
| Article | Year |
|---|---|
Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child, Preschool; Cyclosporine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Male; Pyridones | 2021 |
Drug-induced lupus erythematosus secondary to pirfenidone.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Humans; Idiopathic Pulmonary Fibrosis; Lupus Erythematosus, Systemic; Middle Aged; Pyridones | 2018 |
Pirfenidone combined with corticosteroids in a patient with systemic lupus erythematosus-associated interstitial lung disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Middle Aged; Prednisone; Pyridones | 2017 |